Published in Eur J Gastroenterol Hepatol on September 01, 1999
Liver in systemic disease. World J Gastroenterol (2008) 1.04
Hepatic manifestations in hematological disorders. Int J Hepatol (2013) 0.79
Before it crumbles: Fulminant Hepatic Failure secondary to Hodgkin's Lymphoma. J Community Hosp Intern Med Perspect (2014) 0.79
Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin's lymphoma: a case report and review of the literature. BMC Res Notes (2014) 0.79
Hodgkin's lymphoma coexisting with liver failure secondary to acute on chronic hepatitis B. World J Clin Cases (2013) 0.78
Febrile cholestatic disease as an initial presentation of nodular lymphocyte-predominant Hodgkin lymphoma. World J Gastroenterol (2010) 0.77
Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review. World J Gastroenterol (2017) 0.75
Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med (1985) 8.45
Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med (1989) 6.37
Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med (1993) 5.39
Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol (1998) 3.94
Connective tissue polarity. Optical second-harmonic microscopy, crossed-beam summation, and small-angle scattering in rat-tail tendon. Biophys J (1986) 3.78
Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med (1985) 3.41
Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst (2000) 3.27
Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. N Engl J Med (1981) 3.17
Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst (1988) 3.09
Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet (1991) 2.70
Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus. Hepatology (1983) 2.36
Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial. Cancer (1977) 2.16
Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: comparison to HBeAg/anti-HBe status in HBsAg carriers. Hepatology (1983) 2.10
Direct measurement of the 7Be solar neutrino flux with 192 days of borexino data. Phys Rev Lett (2008) 1.93
Multiple systems organ failure from organophosphate poisoning. J Toxicol Clin Toxicol (1995) 1.79
Intracranial ependymomas of childhood: long-term outcome and prognostic factors. Neurosurgery (1995) 1.66
A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Breast and Bowel Project Protocol R-03. Dis Colon Rectum (1997) 1.58
Differentiating malignant from benign ovarian tumors with transvaginal color flow imaging. Obstet Gynecol (1992) 1.57
Second-harmonic microscopy of biological tissue. Opt Lett (1986) 1.55
Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg (2001) 1.44
Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J Clin Oncol (2000) 1.44
The long-term outcome of interferon-alpha treated and untreated patients with HBeAg-negative chronic hepatitis B. J Hepatol (2001) 1.39
Breast conservation therapy: are therapists too conservative? Int J Radiat Oncol Biol Phys (1992) 1.39
Adaptation of the cellscan technique for the SCM test in breast cancer. Eur J Cancer (1996) 1.39
Interferon alpha treatment and retreatment of hepatitis B e antigen-negative chronic hepatitis B. Gastroenterology (2001) 1.38
Primary cancers of extrahepatic biliary passages. Int J Radiat Oncol Biol Phys (1985) 1.29
Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990. Int J Radiat Oncol Biol Phys (1992) 1.28
Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE grafts. Ann Thorac Surg (2001) 1.27
Association of intron phases with conservation at splice site sequences and evolution of spliceosomal introns. Mol Biol Evol (1999) 1.26
Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases. J Neurosurg (1995) 1.25
Old and emerging therapies in chronic hepatitis C: an update. J Viral Hepat (2008) 1.22
Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis. Aliment Pharmacol Ther (2001) 1.20
Hepatitis-associated antigen in chronic liver disease. Lancet (1970) 1.19
Low dose methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell lines to a greater extent than in monocytic lines. Inflamm Res (2005) 1.18
Neurofibromatosis and childhood tumors. Cancer (1986) 1.17
Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature. HENCORE Group. (Hepatitis C European Network for Co-operative Research. Eur J Gastroenterol Hepatol (2000) 1.16
Time of death of CNS tumor-bearing rats can be reliably predicted by body weight-loss patterns. Lab Anim Sci (1991) 1.16
Malignant gastrointestinal melanomas of unknown origin: should it be considered primary? World J Gastroenterol (2007) 1.14
Clinical in vitro endothelialization of femoropopliteal bypass grafts: an actuarial follow-up over three years. J Vasc Surg (1994) 1.11
Diagnosis and management of pre-core mutant chronic hepatitis B. J Viral Hepat (2001) 1.10
Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis. Gut (2003) 1.08
Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis. J Viral Hepat (2006) 1.07
Over-expression of p53 nuclear oncoprotein in colorectal adenomas. Int J Cancer (1992) 1.07
The value of myelography in the management of childhood medulloblastoma. Cancer (1980) 1.07
Total anomalous pulmonary venous return. Review of 125 patients treated surgically. Ann Thorac Surg (1975) 1.06
Changes in epidemiological patterns of HCV infection and their impact on liver disease over the last 20 years in Greece. J Viral Hepat (2005) 1.06
Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection. Gut (2007) 1.05
Liver disease activity and hepatitis B virus replication in chronic delta antigen-positive hepatitis B virus carriers. Hepatology (1985) 1.05
Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: a randomized, controlled trial. Hepatology (1995) 1.05
Desmoid tumor presenting as intra-abdominal abscess. Dig Dis Sci (2006) 1.04
Interrupted replication of hepatitis B virus in liver tissue of HBsAg carriers with hepatocellular carcinoma. Virology (1988) 1.02
Alpha-chain disease with clinical, immunological, and histological recovery. Br Med J (1974) 1.02
Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e antigen-negative patients. J Viral Hepat (1998) 1.02
Cholestatic jaundice as a paraneoplastic manifestation of renal cell carcinoma. Eur J Gastroenterol Hepatol (1997) 1.00
Evaluation of the prognostic and predictive value of p53 and Bcl-2 in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy. Ann Oncol (2006) 1.00
Radiotherapy for intracranial metastases. Cancer (1974) 0.98
Rhabdomyosarcoma of the ear-mastoid. Laryngoscope (1974) 0.97
Cirrhosis but not neutropenia is associated with the development of infection in patients with chronic hepatitis C undergoing treatment with pegylated interferon-alpha and ribavirin. J Viral Hepat (2013) 0.96
Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alfa-2b for 6 or 12 months: a 4-year follow-up of 211 patients. Hepatology (1997) 0.96
Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin. J Viral Hepat (2008) 0.95
Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C. J Viral Hepat (2010) 0.94
Review article: current management of chronic hepatitis B. Aliment Pharmacol Ther (2004) 0.94
Metformin hepatotoxicity. Ann Intern Med (2004) 0.94
Case 3. Grey-Turner's sign as the first indication of a ruptured hepatocellular carcinoma. J Clin Oncol (2004) 0.94
Radiotherapy for malignancies associated with lupus: case reports of acute and late reactions. Am J Clin Oncol (1998) 0.93
Crystallinity of the double layer of cadmium arachidate films at the water surface. Science (1991) 0.92
Lumpectomy and axillary dissection for breast cancer: surgical, pathological, and radiation considerations. World J Surg (1985) 0.92
Radiotherapy of nonfunctional adenomas of the pituitary gland. Results with long-term follow-up. Cancer (1989) 0.91
Peginterferon alpha-2a (40 kDa) and ribavirin: comparable rates of sustained virological response in sub-sets of older and younger HCV genotype 1 patients. J Viral Hepat (2009) 0.91
Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirin. J Viral Hepat (2013) 0.90
Rhabdomyosarcoma of the middle cranial fossa. Cancer (1973) 0.90
Surface tension measurements of surface freezing in liquid normal alkanes. Science (1993) 0.90
Acute lymphocytic leukemia of the ovary: the value of sonography. J Comput Tomogr (1982) 0.90
Gliclazide-induced acute hepatitis. Eur J Gastroenterol Hepatol (2000) 0.89
Cancer of the nasopharynx in children. Cancer (1978) 0.89
Radiotherapy for primary brain tumors in very young children. Cancer (1982) 0.89
Management of low-grade gliomas of the optic nerve and chiasm. Cancer (1988) 0.88
Pegylated interferon-2b-associated autoimmune thrombocytopenia in a patient with chronic hepatitis C. Am J Gastroenterol (2003) 0.88
Breast tumor recurrence following lumpectomy with and without breast irradiation: an overview of recent NSABP findings. Semin Surg Oncol (1992) 0.88
Reversal of liver failure in sickle cell vaso-occlusive crisis. Am J Med Sci (1996) 0.88
A Synchrotron X-ray Study of a Solid-Solid Phase Transition in a Two-Dimensional Crystal. Science (1988) 0.88
Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis. Aliment Pharmacol Ther (2007) 0.87
Radiation treatment of orbital lymphoid hyperplasia. Ophthalmology (1979) 0.87
Hemangioendothelioma of the penis with late appearing metastases: report of a case with review of the literature. J Surg Oncol (1973) 0.86
Immune thrombocytopenia and alpha-interferon therapy. J Hepatol (1996) 0.86
Methotrexate selectively modulates TH1/TH2 balance in active rheumatoid arthritis patients. Clin Exp Rheumatol (2008) 0.86
Hepatocellular carcinoma and type B hepatitis. Clin Gastroenterol (1980) 0.86
Eight years of clinical endothelial cell transplantation. Closing the gap between prosthetic grafts and vein grafts. ASAIO J (1998) 0.86
Endothelial cell transplantation. Semin Vasc Surg (1999) 0.85